Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer
Clinical trial NCT07238283 · RECRUITING
Trial details
- NCT number
- NCT07238283
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-02
- Primary completion
- 2028-10-01
- Enrollment
- 662
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.